| Year |
Citation |
Score |
| 2022 |
Davdison SM, Schmidt DR, Heyman JE, O'Brien JP, Liu AC, Israelsen WJ, Dayton TL, Sehgal R, Bronson RT, Freinkman E, Mak HH, Fanelli GN, Malstrom S, Bellinger G, Carracedo A, ... ... Courtney KD, et al. Pyruvate kinase M1 suppresses development and progression of prostate adenocarcinoma. Cancer Research. PMID 35584006 DOI: 10.1158/0008-5472.CAN-21-2352 |
0.615 |
|
| 2019 |
Brugarolas J, Courtney KD, Ma Y, Diaz de Leon A, Christie A, Xie Z, Woolford L, Singla N, Joyce A, Hill H, Madhuranthakam AJ, Yuan Q, Xi Y, Zhang Y, Chang J, et al. HIF-2 Complex Dissociation, Target Inhibition, and Acquired Resistance with PT2385, a First-in-Class HIF-2 Inhibitor in Clear Cell Renal Cell Carcinoma Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31727677 DOI: 10.1158/1078-0432.Ccr-19-1459 |
0.328 |
|
| 2019 |
Desai NB, Courtney K, Subramaniam RM, Cadeddu JA. Salvage Radiotherapy for Nodal Oligorecurrent Prostate Cancer: A Step Towards Predictive Criteria for Metastasis-Directed Therapy in Prostate Cancer? European Urology. PMID 31421942 DOI: 10.1016/J.Eururo.2019.07.050 |
0.305 |
|
| 2019 |
Zhang Y, Schoenhals J, Christie A, Mohamad O, Wang C, Bowman I, Singla N, Hammers H, Courtney K, Bagrodia A, Margulis V, Desai N, Garant A, Choy H, Brugarolas J, et al. Stereotactic Ablative Radiotherapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer. International Journal of Radiation Oncology, Biology, Physics. PMID 31377159 DOI: 10.1016/J.Ijrobp.2019.07.023 |
0.306 |
|
| 2019 |
Zhang Y, Schoenhals J, Christie A, Wang C, Mohamad O, Singla N, Desai N, Choy H, Courtney KD, Bagrodia A, Margulis V, Bowman IA, Timmerman RD, Brugarolas J, Hannan R. Outcomes of stereotactic ablative radiotherapy for extra-cranial oligo-metastatic renal cell cancer. Journal of Clinical Oncology. 37: 599-599. DOI: 10.1200/Jco.2019.37.7_Suppl.599 |
0.318 |
|
| 2018 |
Courtney KD, Bezwada D, Mashimo T, Pichumani K, Vemireddy V, Funk AM, Wimberly J, McNeil SS, Kapur P, Lotan Y, Margulis V, Cadeddu JA, Pedrosa I, DeBerardinis RJ, Malloy CR, et al. Isotope Tracing of Human Clear Cell Renal Cell Carcinomas Demonstrates Suppressed Glucose Oxidation In Vivo. Cell Metabolism. PMID 30146487 DOI: 10.1016/J.Cmet.2018.07.020 |
0.312 |
|
| 2018 |
Kobayashi M, Chung JS, Beg M, Arriaga Y, Verma UN, Courtney K, Mansour JC, Haley B, Khan SA, Horiuchi Y, Ramani V, Harker D, Gopal P, Araghizadeh F, Cruz PD, et al. Blocking monocytic myeloid-derived suppressor cell function via anti-DC-HIL/GPNMB antibody restores the in vitro integrity of T-cells from cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 30049749 DOI: 10.1158/1078-0432.Ccr-18-0330 |
0.311 |
|
| 2018 |
Wang JS, Barve MA, Chiorean EG, LoRusso P, Courtney KD, Qi D, Olguin A, Bullington J, Sardone M, Dunn V, Shemesh S, Chen J, Brooks C, Bauer TM. Interim results from a phase 1 trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumors. Journal of Clinical Oncology. 36: 2560-2560. DOI: 10.1200/Jco.2018.36.15_Suppl.2560 |
0.353 |
|
| 2017 |
Tumati V, Jackson WC, Abugharib AE, Raj G, Roehrborn C, Lotan Y, Courtney K, Bagrodia A, Gahan JC, Zumsteg ZS, Folkert MR, Laine AM, Hannan R, Spratt DE, Desai NB. Natural History of 'Second' Biochemical Failure Following Salvage Radiation Therapy for Prostate Cancer: A Multi-Institution Study. Bju International. PMID 28581200 DOI: 10.1111/Bju.13926 |
0.301 |
|
| 2017 |
Li J, Alyamani M, Zhang A, Chang KH, Berk M, Li Z, Zhu Z, Petro M, Magi-Galluzzi C, Taplin ME, Garcia JA, Courtney K, Klein EA, Sharifi N. Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer. Elife. 6. PMID 28191869 DOI: 10.7554/Elife.20183 |
0.34 |
|
| 2017 |
Sharifi N, Li J, Alyamani M, Zhang A, Chang K, Berk M, Li Z, Zhu Z, Petro M, Taplin M, Garcia JA, Courtney KD, Klein EA. Aberrant tumor metabolism to enable glucocorticoid receptor takeover in enzalutamide-resistant prostate cancer. Journal of Clinical Oncology. 35: 157-157. DOI: 10.1200/Jco.2017.35.6_Suppl.157 |
0.324 |
|
| 2017 |
Kobayashi M, Chung J, Beg M, Arriaga Y, Verma U, Courtney K, Mansour J, Haley B, Khan S, Horiuchi Y, Harker D, Gopal P, Cruz PD, Ariizumi K. Abstract 3660: Blocking the DC-HIL receptor reverses the T-cell suppression induced by proliferating myeloid-derived suppressor cells in common cancer types Cancer Research. 77: 3660-3660. DOI: 10.1158/1538-7445.Am2017-3660 |
0.328 |
|
| 2016 |
Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, ... ... Courtney K, et al. Targeting Renal Cell Carcinoma with a HIF-2 antagonist. Nature. PMID 27595394 DOI: 10.1038/Nature19796 |
0.32 |
|
| 2016 |
Li J, Alyamani M, Zhang A, Chang K, Berk M, Li Z, Zhu Z, Petro M, Magi-Galluzzi C, Taplin M, Garcia JA, Courtney K, Klein EA, Sharifi N. Author response: Aberrant corticosteroid metabolism in tumor cells enables GR takeover in enzalutamide resistant prostate cancer Elife. DOI: 10.7554/Elife.20183.013 |
0.348 |
|
| 2015 |
Courtney KD, Manola JB, Elfiky AA, Ross R, Oh WK, Yap JT, Van den Abbeele AD, Ryan CW, Beer TM, Loda M, Priolo C, Kantoff P, Taplin ME. A phase I study of everolimus and docetaxel in patients with castration-resistant prostate cancer. Clinical Genitourinary Cancer. 13: 113-23. PMID 25450031 DOI: 10.1016/J.Clgc.2014.08.007 |
0.304 |
|
| 2014 |
Westphal AJ, Anderson D, Butterworth AL, Frank DR, Lettieri R, Marchant W, Von Korff J, Zevin D, Ardizzone A, Campanile A, Capraro M, Courtney K, Criswell MN, Crumpler D, Cwik R, et al. Stardust Interstellar Preliminary Examination I: Identification of tracks in aerogel Meteoritics and Planetary Science. DOI: 10.1111/Maps.12168 |
0.451 |
|
| 2013 |
Emerling BM, Benes CH, Poulogiannis G, Bell EL, Courtney K, Liu H, Choo-Wing R, Bellinger G, Tsukazawa KS, Brown V, Signoretti S, Soltoff SP, Cantley LC. Identification of CDCP1 as a hypoxia-inducible factor 2α (HIF-2α) target gene that is associated with survival in clear cell renal cell carcinoma patients. Proceedings of the National Academy of Sciences of the United States of America. 110: 3483-8. PMID 23378636 DOI: 10.1073/Pnas.1222435110 |
0.554 |
|
| 2013 |
Emerling BM, Benes C, Bell E, Poulogiannis G, Courtney K, Lui H, Choo-Wing R, Bellinger G, Soltoff S, Cantley L. Abstract 4588: Identification of CDCP1 as a HIF-2α target gene involved in the regulation of cancer cell migration and metastasis. Cancer Research. 73: 4588-4588. DOI: 10.1158/1538-7445.Am2013-4588 |
0.546 |
|
| 2012 |
Nakabayashi M, Werner L, Courtney KD, Buckle G, Oh WK, Bubley GJ, Hayes JH, Weckstein D, Elfiky A, Sims DM, Kantoff PW, Taplin ME. Phase II trial of RAD001 and bicalutamide for castration-resistant prostate cancer. Bju International. 110: 1729-35. PMID 22928480 DOI: 10.1111/J.1464-410X.2012.11456.X |
0.373 |
|
| 2012 |
Anastasiou D, Yu Y, Israelsen WJ, Jiang JK, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A, Yang H, Mattaini KR, Metallo CM, Fiske BP, Courtney KD, et al. Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis. Nature Chemical Biology. 8: 839-47. PMID 22922757 DOI: 10.1038/Nchembio.1060 |
0.635 |
|
| 2012 |
Patnaik A, Courtney K, Robichaud K, Bellinger G, Nardella C, Signoretti S, Wooster R, Pandolfi PP, Cantley L. Abstract LB-365: Effective use of PI3K/MTOR and MEK inhibitors prior to hormone ablative therapy in PTEN-loss driven murine prostate cancer Cancer Research. 72. DOI: 10.1158/1538-7445.Am2012-Lb-365 |
0.519 |
|
| 2012 |
Anastasiou D, Yu Y, Israelsen WJ, Jiang J, Boxer MB, Hong BS, Tempel W, Dimov S, Shen M, Jha A, Yang H, Mattaini KR, Metallo CM, Fiske BP, Courtney KD, et al. Erratum: Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis Nature Chemical Biology. 8: 1008-1008. DOI: 10.1038/Nchembio1212-1008B |
0.47 |
|
| 2011 |
Patnaik A, Courtney K, Bellinger G, Lunsford E, Robichaud K, Grant A, Lenkinski R, Pedrosa I, Signoretti S, Wooster R, Cantley L. Abstract LB-418: Targeting the PI3K/mTOR pathway in genetically engineered mouse models of prostate cancer Cancer Research. 71. DOI: 10.1158/1538-7445.Am2011-Lb-418 |
0.511 |
|
| 2010 |
Courtney KD, Choueiri TK. Updates on novel therapies for metastatic renal cell carcinoma. Therapeutic Advances in Medical Oncology. 2: 209-19. PMID 21789135 DOI: 10.1177/1758834010361470 |
0.33 |
|
| 2010 |
Courtney KD, Corcoran RB, Engelman JA. The PI3K pathway as drug target in human cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 1075-83. PMID 20085938 DOI: 10.1200/Jco.2009.25.3641 |
0.393 |
|
| 2009 |
Courtney KD, Choueiri TK. Optimizing recent advances in metastatic renal cell carcinoma. Current Oncology Reports. 11: 218-26. PMID 19336014 DOI: 10.1007/S11912-009-0031-5 |
0.342 |
|
| 2008 |
Shaywitz AJ, Courtney KD, Patnaik A, Cantley LC. PI3K enters beta-testing. Cell Metabolism. 8: 179-81. PMID 18762017 DOI: 10.1016/J.Cmet.2008.08.011 |
0.47 |
|
| 2001 |
Stradal T, Courtney KD, Rottner K, Hahne P, Small JV, Pendergast AM. The Abl interactor proteins localize to sites of actin polymerization at the tips of lamellipodia and filopodia. Current Biology : Cb. 11: 891-5. PMID 11516653 DOI: 10.1016/S0960-9822(01)00239-1 |
0.608 |
|
| 2000 |
Courtney KD, Grove M, Vandongen H, Vandongen A, LaMantia AS, Pendergast AM. Localization and phosphorylation of Abl-interactor proteins, Abi-1 and Abi-2, in the developing nervous system. Molecular and Cellular Neurosciences. 16: 244-57. PMID 10995551 DOI: 10.1006/Mcne.2000.0865 |
0.616 |
|
| 2000 |
Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS, Pendergast AM. Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases. Blood. 95: 2913-21. PMID 10779439 |
0.597 |
|
| 2000 |
Quackenbush RC, Reuther GW, Miller JP, Courtney KD, Pear WS, Pendergast AM. Analysis of the biologic properties of p230 Bcr-Abl reveals unique and overlapping properties with the oncogenic p185 and p210 Bcr-Abl tyrosine kinases Blood. 95: 2913-2921. DOI: 10.1182/Blood.V95.9.2913.009K32_2913_2921 |
0.695 |
|
| 1998 |
Dai Z, Quackenbush RC, Courtney KD, Grove M, Cortez D, Reuther GW, Pendergast AM. Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway. Genes & Development. 12: 1415-24. PMID 9585502 DOI: 10.1101/Gad.12.10.1415 |
0.704 |
|
| Low-probability matches (unlikely to be authored by this person) |
| 2020 |
Rana HQ, Stopfer JE, Petrucelli N, Koeller DR, Pirzadeh-Miller S, Reys B, Kipnis L, Culver S, Vatnick DR, Silver R, Mercado J, Gelman RS, Weitz M, Speare V, Dolinsky JS, ... ... Courtney KD, et al. A randomized controlled trial of video-education or in-person genetic counseling for men with prostate cancer (ProGen). Journal of Clinical Oncology. 38: 1507-1507. DOI: 10.1200/Jco.2020.38.15_Suppl.1507 |
0.298 |
|
| 2017 |
Courtney KD, Infante JR, Lam ET, Figlin RA, Rini BI, Brugarolas J, Zojwalla NJ, Lowe AM, Wang K, Wallace EM, Josey JA, Choueiri TK. Phase I Dose-Escalation Trial of PT2385, a First-in-Class Hypoxia-Inducible Factor-2α Antagonist in Patients With Previously Treated Advanced Clear Cell Renal Cell Carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017742627. PMID 29257710 DOI: 10.1200/Jco.2017.74.2627 |
0.297 |
|
| 2012 |
Courtney KD, Taplin ME. The evolving paradigm of second-line hormonal therapy options for castration-resistant prostate cancer. Current Opinion in Oncology. 24: 272-7. PMID 22327837 DOI: 10.1097/Cco.0B013E328351059D |
0.296 |
|
| 2018 |
Bowman IA, Bent A, Le T, Christie A, Wardak Z, Arriaga Y, Courtney K, Hammers H, Barnett S, Mickey B, Patel T, Whitworth T, Stojadinovic S, Hannan R, Nedzi L, et al. Improved Survival Outcomes for Kidney Cancer Patients With Brain Metastases. Clinical Genitourinary Cancer. PMID 30538068 DOI: 10.1016/J.Clgc.2018.11.007 |
0.295 |
|
| 2016 |
Courtney KD, Infante JR, Lam ET, Figlin RA, Rini BI, Brugarolas J, Zojwalla NJ, Wang K, Wallace E, Josey JA, Choueiri TK. A phase I dose escalation trial of PT2385, a first-in-class oral HIF-2a inhibitor, in patients with advanced clear cell renal cell carcinoma. Journal of Clinical Oncology. 34: 2506-2506. DOI: 10.1200/Jco.2016.34.15_Suppl.2506 |
0.292 |
|
| 2020 |
Rao A, Zaha V, Bermas B, Lohrey J, Courtney KD, Hammers HJ, Gerber DE, Garg S, Mammen PP. Immune checkpoint inhibition-induced myocarditis in cancer patients: Proposal of a detection and management strategy. Journal of Clinical Oncology. 38. DOI: 10.1200/Jco.2020.38.15_Suppl.E15116 |
0.283 |
|
| 2020 |
Chertack N, Ghandour RA, Singla N, Freifeld Y, Hutchinson RC, Courtney K, Bowman IA, Arafat W, Meng X, Moore JA, Aydin AM, Sagalowsky AI, Margulis V, Lotan Y, Woldu SL, et al. Overcoming sociodemographic factors in the care of patients with testicular cancer at a safety net hospital. Cancer. PMID 32776520 DOI: 10.1002/Cncr.33076 |
0.281 |
|
| 2018 |
Bauer TM, Barve M, Chiorean EG, Lorusso P, Courtney K, Qi D, Olguin A, Bullington J, Sardone M, Dunn V, Shemesh S, Chen J, Brooks C, Wang J. Interim results from a phase I trial of SL-801: A novel XPO-1 inhibitor, in patients with advanced solid tumors. Annals of Oncology. 29. DOI: 10.1093/Annonc/Mdy279.415 |
0.28 |
|
| 2017 |
Wang J, Nemunaitis J, Chiorean G, Lorusso P, Courtney K, Olguin A, Bullington J, Shemesh S, Chen J, Brooks C, Bauer TM. 406POngoing phase 1 trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumors; Interim results Annals of Oncology. 28. DOI: 10.1093/Annonc/Mdx367.039 |
0.28 |
|
| 2018 |
Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, Silva Dos Santos M, MacRae JI, O'Reilly N, Wright AJ, Benes CH, ... Courtney KD, et al. MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nature Chemical Biology. PMID 30297875 DOI: 10.1038/S41589-018-0136-Y |
0.278 |
|
| 2019 |
Awosanya T, Hamidi O, Courtney K. MON-362 Undiagnosed Non-classic Congenital Adrenal Hyperplasia as a Driving Force for Persistent Hyperandrogenemia in Prostate Cancer Journal of the Endocrine Society. 3. DOI: 10.1210/Js.2019-Mon-362 |
0.277 |
|
| 2020 |
Hammers HJ, Vonmerveldt D, Ahn C, Nadal RM, Drake CG, Folkert MR, Laine AM, Courtney KD, Brugarolas J, Song DY, Hannan R, Carducci MA. Combination of dual immune checkpoint inhibition (ICI) with stereotactic radiation (SBRT) in metastatic renal cell carcinoma (mRCC) (RADVAX RCC). Journal of Clinical Oncology. 38: 614-614. DOI: 10.1200/Jco.2020.38.6_Suppl.614 |
0.271 |
|
| 2014 |
Krabbe L, Westerman ME, Margulis V, Raj G, Sagalowsky AI, Courtney KD, Arriaga YE, Lotan Y. Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.E15518 |
0.271 |
|
| 2019 |
Schoenhals J, Mohamad O, Christie A, Garant A, Desai NB, Bowman I, Courtney K, Hammers H, Timmerman RD, Brugarolas J, Hannan R. Stereotactic Ablative Radiotherapy for Oligoprogressive Metastatic Renal Cell Carcinoma International Journal of Radiation Oncology Biology Physics. 105. DOI: 10.1016/J.Ijrobp.2019.06.1957 |
0.269 |
|
| 2018 |
Mohamad O, Diaz de Leon A, Schroeder S, Leiker A, Christie A, Zhang-Velten E, Trivedi L, Khan S, Desai NB, Laine A, Albuquerque K, Iyengar P, Arriaga Y, Courtney K, Gerber DE, et al. Safety and efficacy of concurrent immune checkpoint inhibitors and hypofractionated body radiotherapy. Oncoimmunology. 7: e1440168. PMID 29900043 DOI: 10.1080/2162402X.2018.1440168 |
0.267 |
|
| 2016 |
Ishihara D, Louder K, Akter M, Ahn C, Margulis V, Arriaga Y, Courtney K, Timmerman RD, Brugarolas J, Hannan R. Phase 2 Trial of High-Dose Interleukin-2 (IL-2) and Stereotactic Ablative Radiation Therapy (SABR) for Metastatic Clear Cell Renal Cell Carcinoma (mRCC)-Interim Analysis of i-SAbR IL-2 Trial. International Journal of Radiation Oncology, Biology, Physics. 96: S96-S97. PMID 27676061 DOI: 10.1016/J.Ijrobp.2016.06.241 |
0.258 |
|
| 2020 |
Chertack N, Ghandour R, Singla N, Freifeld YN, Hutchinson RC, Courtney KD, Moore JA, Aydin A, Margulis V, Lotan Y, Woldu SL, Bagrodia A. Overcoming sociodemographic factors in the care of testicular cancer patients at a safety net hospital. Journal of Clinical Oncology. 38: 398-398. DOI: 10.1200/Jco.2020.38.6_Suppl.398 |
0.25 |
|
| 2019 |
Wang J, Barve M, Chiorean E, LoRusso P, Courtney K, Qi D, Bullington J, Sardone M, Chen J, Brooks C, Shemesh S, Bauer TM. Interim results from trial of SL-801, a novel XPO-1 inhibitor, in patients with advanced solid tumours Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz244.028 |
0.249 |
|
| 2016 |
Hannan R, Ishihara D, Louder K, Ahn C, Margulis V, Arriaga YE, Courtney KD, Timmerman RD, Brugarolas J. Phase II trial of high-dose interleukin-2 (IL-2) and stereotactic radiation therapy (SABR) for metastatic clear cell renal cell carcinoma (ccRCC): Interim analysis. Journal of Clinical Oncology. 34: 532-532. DOI: 10.1200/Jco.2016.34.2_Suppl.532 |
0.248 |
|
| 2019 |
Grivas P, Puligandla M, Cole S, Courtney KD, Dreicer R, Gartrell BA, Cetnar JP, Dall'era M, Galsky MD, Jain RK, Maughan BL, Agarwal N, Koshkin VS, Hahn NM, Carducci MA. PrE0807 phase Ib feasibility trial of neoadjuvant nivolumab (N)/lirilumab (L) in cisplatin-ineligible muscle-invasive bladder cancer (BC). Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.Tps4594 |
0.244 |
|
| 2019 |
Fets L, Driscoll PC, Grimm F, Jain A, Nunes PM, Gounis M, Doglioni G, Papageorgiou G, Ragan TJ, Campos S, Dos Santos MS, MacRae JI, O'Reilly N, Wright AJ, Benes CH, ... Courtney KD, et al. Author Correction: MCT2 mediates concentration-dependent inhibition of glutamine metabolism by MOG. Nature Chemical Biology. PMID 31645751 DOI: 10.1038/S41589-019-0409-0 |
0.232 |
|
| 2017 |
Mohamad O, Leiker A, Schroeder S, Zhang E, Trivedi L, Gerber D, Khan S, Iyengar P, Albuquerque K, Arriaga Y, Courtney K, Brugarolas J, Hammers H, Timmerman R, Hannan R. Safety and Outcomes of Combining Immune Checkpoint Inhibitors with Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 99: E610-E611. DOI: 10.1016/J.Ijrobp.2017.06.2071 |
0.23 |
|
| 1993 |
Wetterhahn K, Stearns D, Giangrande P, Phieffer L, Courtney K. The role of ascorbate in metabolism and genotoxicity of chromium(VI). Journal of Inorganic Biochemistry. 51: 551. DOI: 10.1016/0162-0134(93)85577-U |
0.226 |
|
| 2021 |
Kinaan M, Hamidi O, Yau H, Courtney KD, Eraslan A, Simon K. Congenital Adrenal Hyperplasia Causing Poor Response to Androgen Deprivation Therapy in Prostate Cancer. Journal of the Endocrine Society. 5: bvaa158. PMID 33294761 DOI: 10.1210/jendso/bvaa158 |
0.194 |
|
| 2022 |
Hannan R, Dohopolski MJ, Pop LM, Mannala S, Watumull L, Mathews D, Gao A, Garant A, Arriaga YE, Bowman I, Chung JS, Wang J, Ariizumi K, Ahn C, Timmerman R, ... Courtney K, et al. Phase II Trial of Sipuleucel-T and Stereotactic Ablative Body Radiation for Patients with Metastatic Castrate-Resistant Prostate Cancer. Biomedicines. 10. PMID 35740441 DOI: 10.3390/biomedicines10061419 |
0.194 |
|
| 2023 |
Bezwada D, Lesner NP, Brooks B, Vu HS, Wu Z, Cai L, Kasitinon S, Kelekar S, Cai F, Aurora AB, Patrick M, Leach A, Ghandour R, Zhang Y, Do D, ... ... Courtney KD, et al. Mitochondrial metabolism in primary and metastatic human kidney cancers. Biorxiv : the Preprint Server For Biology. PMID 36798172 DOI: 10.1101/2023.02.06.527285 |
0.185 |
|
| 2021 |
Hannan R, Christensen M, Hammers H, Christie A, Paulman B, Lin D, Garant A, Arafat W, Courtney K, Bowman I, Cole S, Sher D, Ahn C, Choy H, Timmerman R, et al. Phase II Trial of Stereotactic Ablative Radiation for Oligoprogressive Metastatic Kidney Cancer. European Urology Oncology. PMID 34986993 DOI: 10.1016/j.euo.2021.12.001 |
0.183 |
|
| 2007 |
Memtsoudis SG, Lekowski RW, Rosenberger P, Khalpey Z, FitzGerald DJ, Claypoole V, Courtney KD, Landzberg MJ, Bunn HF, Shekar PS. Pulmonary thrombectomy in a patient with hemoglobin Nottingham. Perfusion. 22: 299-301. PMID 18181520 DOI: 10.1177/0267659107084143 |
0.181 |
|
| 2022 |
Loehr A, Hussain A, Patnaik A, Bryce AH, Castellano D, Font A, Shapiro J, Zhang J, Sautois B, Vogelzang NJ, Chatta G, Courtney K, Harzstark A, Ricci F, Despain D, et al. Emergence of BRCA Reversion Mutations in Patients with Metastatic Castration-resistant Prostate Cancer After Treatment with Rucaparib. European Urology. PMID 36243543 DOI: 10.1016/j.eururo.2022.09.010 |
0.168 |
|
| 2021 |
Meng X, Ahmed M, Courtney KD, Arafat W, Ibrahim I, Margulis V, Nichols C, Bagrodia A. Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer. Frontiers in Oncology. 11: 724682. PMID 34692501 DOI: 10.3389/fonc.2021.724682 |
0.168 |
|
| 2011 |
Courtney KD, Cho DC, Choueiri TK. Emerging and Novel Therapeutic Targets in Renal Cancer Emerging Cancer Therapeutics. 2: 145-156. DOI: 10.5003/2151-4194.2.1.145 |
0.153 |
|
| 2023 |
Rana HQ, Stopfer JE, Weitz M, Kipnis L, Koeller DR, Culver S, Mercado J, Gelman RS, Underhill-Blazey M, McGregor BA, Sweeney CJ, Petrucelli N, Kokenakes C, Pirzadeh-Miller S, Reys B, ... ... Courtney KD, et al. Pretest Video Education Versus Genetic Counseling for Patients With Prostate Cancer: ProGen, A Multisite Randomized Controlled Trial. Jco Oncology Practice. OP2300007. PMID 37733980 DOI: 10.1200/OP.23.00007 |
0.148 |
|
| 2021 |
Hannan R, Mohamad O, Diaz de Leon A, Manna S, Pop LM, Zhang Z, Mannala S, Christie A, Christley S, Monson N, Ishihara D, Hsu EJ, Ahn C, Kapur P, Chen M, ... ... Courtney K, et al. Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 34551906 DOI: 10.1158/1078-0432.CCR-21-2083 |
0.143 |
|
| 2015 |
Krabbe LM, Westerman ME, Margulis V, Raj GV, Sagalowsky AI, Courtney K, Arriaga Y, Lotan Y. Changing trends in utilization of neoadjuvant chemotherapy in muscle-invasive bladder cancer. The Canadian Journal of Urology. 22: 7865-75. PMID 26267024 |
0.133 |
|
| 2021 |
Schoenhals JE, Mohamad O, Christie A, Zhang Y, Li D, Singla N, Bowman I, Arafat W, Hammers H, Courtney K, Cole S, Bagrodia A, Margulis V, Desai N, Garant A, et al. Stereotactic Ablative Radiation Therapy for Oligoprogressive Renal Cell Carcinoma. Advances in Radiation Oncology. 6: 100692. PMID 34646963 DOI: 10.1016/j.adro.2021.100692 |
0.133 |
|
| 2022 |
Hannan R, Christensen M, Christie A, Garant A, Pedrosa I, Robles L, Mannala S, Wang C, Hammers H, Arafat W, Courtney K, Bowman IA, Sher D, Ahn C, Cole S, et al. Stereotactic Ablative Radiation for Systemic Therapy-naïve Oligometastatic Kidney Cancer. European Urology Oncology. PMID 35985982 DOI: 10.1016/j.euo.2022.06.008 |
0.13 |
|
| 1982 |
Courtney KD, Ebron MT. 2,4,5-T effects on cardiac and serum Lactic Dehydrogenase (LDH) and Creatine Kinase (CK) isozymes I. Maternal enzyme activities and isozyme profiles Archives of Environmental Contamination and Toxicology. 11: 128-128. DOI: 10.1007/BF01055198 |
0.126 |
|
| 1977 |
Courtney KD. Mouse teratology studies with chlorodibenzo-p-dioxins. Bulletin of Environmental Contamination and Toxicology. 16: 674-81. PMID 1016755 DOI: 10.1007/BF01685572 |
0.123 |
|
| 1982 |
Courtney KD, Ebron MT. 2,4,5-T effects on cardiac and serum Lactic Dehydrogenase (LDH) and Creatine Kinase (CK) isozymes II. Neonatal enzyme activities and isozyme profiles Archives of Environmental Contamination and Toxicology. 11: 128-128. DOI: 10.1007/BF01055199 |
0.119 |
|
| 1984 |
Courtney KD, Andrews JE, Grady MA, Ebron MT. Postnatal effects of hexachlorobenzene (HCB) on cardiac lactic dehydrogenase (LDH) and creatine kinase (CK) isozymes in CD-1 mice. Toxicology Letters. 22: 223-8. PMID 6474511 DOI: 10.1016/0378-4274(84)90070-5 |
0.104 |
|
| 1982 |
Courtney KD, Ebron MT. 2,4,5-T effects on cardiac and serum lactic dehydrogenase (LDH) and creatine kinase (CK) isozymes. I. Maternal enzyme activities and isozyme profiles. Archives of Environmental Contamination and Toxicology. 10: 571-81. PMID 7305449 DOI: 10.1007/BF01054880 |
0.093 |
|
| 1982 |
Courtney KD, Ebron MT. 2,4,5-T effects on cardiac and serum lactic dehydrogenase (LDH) and creatine kinase (CK) isozymes. II. Neonatal enzyme activities and isozyme profiles. Archives of Environmental Contamination and Toxicology. 10: 583-95. PMID 7305450 DOI: 10.1007/BF01054881 |
0.091 |
|
| 1972 |
Courtney KD, Moore JA. Teratology studies with 2,4,5-trichlorophenoxyacetic acid and 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicology and Applied Pharmacology. 20: 396-403. PMID 5132781 DOI: 10.1016/0041-008X(71)90282-1 |
0.076 |
|
| 1998 |
ELLMAN GL, COURTNEY KD, ANDRES V, FEATHER-STONE RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemical Pharmacology. 7: 88-95. PMID 13726518 DOI: 10.1016/0006-2952(61)90145-9 |
0.072 |
|
| 1979 |
Courtney KD, Putnam JP, Andrews JE. Metabolic studies with TCDD (dioxin) treated rats. Archives of Environmental Contamination and Toxicology. 7: 385-96. PMID 755441 DOI: 10.1007/BF02332066 |
0.062 |
|
| 1983 |
Andrews JE, Courtney KD, Donaldson WE. The effects of ethylene chlorohydrin on fatty acid synthesis. Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes. 18: 351-67. PMID 6308094 DOI: 10.1080/03601238309372374 |
0.062 |
|
| 1979 |
Courtney KD, Ebron MT. Isozyme profiles of lactic dehydrogenase and creatine phosphokinase in neonatal mouse hearts. Biology of the Neonate. 34: 203-8. PMID 737243 DOI: 10.1159/000241128 |
0.059 |
|
| 1984 |
Courtney KD, Andrews JE. Teratogenic evaluation and fetal deposition of hexabromobenzene (HBB) and hexafluorobenzene (HFB) in CD-1 mice. Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes. 19: 83-94. PMID 6715792 DOI: 10.1080/03601238409372416 |
0.053 |
|
| 1977 |
Courtney KD. Prenatal effects of herbicides: evaluation by the prenatal development index. Archives of Environmental Contamination and Toxicology. 6: 33-46. PMID 907374 DOI: 10.1007/BF02097747 |
0.05 |
|
| 1988 |
Andrews JE, Courtney KD, Donaldson WE. Impairment of calcium homeostasis by hexachlorobenzene (HCB) exposure in Fischer 344 rats. Journal of Toxicology and Environmental Health. 23: 311-20. PMID 3351979 DOI: 10.1080/15287398809531117 |
0.049 |
|
| 1970 |
Courtney KD, Gaylor DW, Hogan MD, Falk HL, Bates RR, Mitchell I. Teratogenic evaluation of 2,4,5-T. Science (New York, N.Y.). 168: 864-6. PMID 5309824 DOI: 10.1126/science.168.3933.864 |
0.049 |
|
| 1986 |
Courtney KD, Andrews JE, Springer J. Assessment of teratogenic potential of trichlorfon in mice and rats Journal of Environmental Science and Health, Part B. 21: 207-227. PMID 3745797 DOI: 10.1080/03601238609372519 |
0.047 |
|
| 1982 |
Courtney KD, Andrews JE, Grady M. Teratogenic evaluation of ethylene chlorhydrin (ECh, 2-chlorethanol) in mice. Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes. 17: 381-91. PMID 7108147 DOI: 10.1080/03601238209372328 |
0.042 |
|
| 1994 |
Stearns DM, Courtney KD, Giangrande PH, Phieffer LS, Wetterhahn KE. Chromium(VI) reduction by ascorbate: role of reactive intermediates in DNA damage in vitro. Environmental Health Perspectives. 102: 21-5. PMID 7843100 DOI: 10.1289/Ehp.94102S321 |
0.041 |
|
| 1985 |
Courtney KD, Andrews JE. Neonatal and maternal body burdens of hexachlorobenzene (HCB) in mice: gestational exposure and lactational transfer. Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology. 5: 265-77. PMID 3987998 DOI: 10.1016/0272-0590(85)90074-0 |
0.039 |
|
| 1985 |
Courtney KD, Andrews JE, Springer J, Dalley L. Teratogenic evaluation of the pesticides baygon, carbofuran, dimethoate and EPN. Journal of Environmental Science and Health. Part. B, Pesticides, Food Contaminants, and Agricultural Wastes. 20: 373-406. PMID 4045104 DOI: 10.1080/03601238509372485 |
0.039 |
|
| 1977 |
Courtney KD, Ebron MT, Tucker AW. Distribution of 2,4,5-trichlorophenoxyacetic acid in the mouse fetus Toxicology Letters. 1: 103-108. DOI: 10.1016/0378-4274(77)90029-7 |
0.038 |
|
| 1986 |
COURTNEY KD, ANDREWS JE, SPRINGER J, MÉNACHE M, WILLIAMS T, DALLEY L, GRAHAM JA. A Perinatal Study of Toluene in CD-1 Mice Toxicological Sciences. 6: 145-154. DOI: 10.1093/toxsci/6.1.145 |
0.035 |
|
| 1985 |
Courtney KD, Andrews JE, Grady MA. Placental transfer and fetal deposition of hexachlorobenzene in the hamster and guinea pig. Environmental Research. 37: 239-49. PMID 3996340 DOI: 10.1016/0013-9351(85)90061-1 |
0.033 |
|
| 1995 |
Stearns DM, Kennedy LJ, Courtney KD, Giangrande PH, Phieffer LS, Wetterhahn KE. Reduction of chromium(VI) by ascorbate leads to chromium-DNA binding and DNA strand breaks in vitro. Biochemistry. 34: 910-9. PMID 7827049 DOI: 10.1021/Bi00003A025 |
0.026 |
|
| 1955 |
Courtney KD. Human Folly: To Disarm or Perish? International Affairs. 31: 496-497. DOI: 10.2307/2604842 |
0.026 |
|
| 1976 |
Courtney KD, Copeland MF, Robbins A. The effects of pentachloronitrobenzene, hexachlorobenzene, and related compounds on fetal development. Toxicology and Applied Pharmacology. 35: 239-56. PMID 1265744 DOI: 10.1016/0041-008X(76)90285-4 |
0.02 |
|
| 1980 |
Courtney KD, Andrews JE, Svendsgaard DJ. Hexachlorobenzene (HCB) deposition in maternal and fetal tissues of rat and mouse. I. Chemical quantification of HCB in tissues. Environmental Research. 19: 1-13. PMID 510261 DOI: 10.1016/0013-9351(79)90028-8 |
0.016 |
|
| 1980 |
Svendsgaard DJ, Courtney KD, Andrews JE. Hexachlorobenzene (HCB) deposition in maternal and fetal tissues of rat and mouse. II. Statistical quantification of HCB in tissues. Environmental Research. 20: 267-81. PMID 546637 DOI: 10.1016/0013-9351(79)90002-1 |
0.015 |
|
| 1971 |
Gilbert DL, Franko BV, Ward JW, Woodard G, Courtney KD. Toxicologic studies of fenfluramine. Toxicology and Applied Pharmacology. 19: 705-11. PMID 5002290 DOI: 10.1016/0041-008X(71)90302-4 |
0.015 |
|
| 1947 |
Courtney KD. Le Preambule de la Charte, Base Ideologique de L'O.N.U International Affairs. 23: 383-383. DOI: 10.2307/3017245 |
0.013 |
|
| 1979 |
Courtney KD. Chlorinated Phenoxy Acids and Their Dioxins: Mode of Action, Health Risks and Environmental Effects.C. Ramel The Quarterly Review of Biology. 54: 111-112. DOI: 10.1086/411102 |
0.012 |
|
| 1979 |
Courtney K, Andrews JE. Mobilization of hexachlorobenzene (HCB) during gestation Toxicology Letters. 3: 357-361. DOI: 10.1016/0378-4274(79)90147-4 |
0.012 |
|
| 2014 |
COURTNEY K, LITTLE G. Standing Up for Education: building a national campaign Forum. 56: 299. DOI: 10.2304/FORUM.2014.56.2.299 |
0.01 |
|
| 2017 |
Courtney K. Choices have to be made… Seced. 2017: 10-10. DOI: 10.12968/sece.2017.17.10a |
0.01 |
|
| 2016 |
Courtney K. Sprinklers: An illogical decision Seced. 2016: 10-10. DOI: 10.12968/sece.2016.27.10a |
0.01 |
|
| 1980 |
Courtney KD. Hexachlorobenzene (HCB): a review. Environmental Research. 20: 225-66. PMID 121077 DOI: 10.1016/0013-9351(79)90001-X |
0.01 |
|
| 1971 |
Courtney KD, Valerio DA. Teratology in the Macaca mulatta. Teratology. 1: 163-72. PMID 4321743 DOI: 10.1002/tera.1420010205 |
0.01 |
|
| 1969 |
Valerio DA, Pallotta AJ, Courtney KD. Experiences in large-scale breeding of simians for medical experimentation. Annals of the New York Academy of Sciences. 162: 282-96. PMID 4979552 DOI: 10.1111/j.1749-6632.1969.tb56375.x |
0.01 |
|
| 1953 |
Courtney KD. Noel Buxton: a Life International Affairs. 29: 481-481. DOI: 10.2307/2606023 |
0.01 |
|
| 1946 |
Courtney KD. Peace, Security and The United Nations International Affairs. 22: 541-541. DOI: 10.2307/3018197 |
0.01 |
|
| Hide low-probability matches. |
